<DOC>
	<DOCNO>NCT00179231</DOCNO>
	<brief_summary>The study involve six-month , double-blind protocol eighty patient , across three site around country , randomly assign receive clozapine olanzapine . The specific aim study evaluate relative effect olanzapine clozapine clinical outcome cognition patient diagnose schizophrenia schizoaffective disorder demonstrate resistance treatment past .</brief_summary>
	<brief_title>Olanzapine Versus Clozapine Treatment Refractory Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>1 . Patients male female , age 1860 , definite diagnosis DSMIV criterion schizophrenia ( subtype ) schizoaffective disorder . 2 . 2 ) All participant refractory accord Kane et al ( 1988 ) criterion , modification number drug trial least two neuroleptic drug adequate dos period &gt; 3 month . The criterion Kane et al . treatment resistance follow : three trial antipsychotic drug adequate dose duration ( usually 46 week ) . The original criterion involve three type typical neuroleptic drug . Now , include antipsychotic drug clozapine . Olanzapine may try dose must exceed 30 mg/day . 3 . Subjects must PANNSderived BPRS total score &gt; 24 ( 06 scale ) BPRS positive subscale item score &gt; 3 least two four item . 4 . Participants generally good stable physical health . 5 . Written inform consent obtain participant full explanation study procedure . For patient legal guardian , write informed consent obtain guardian , verbal assent research subject . 6 . Since clozapine olanzapine approve agent , specific birth control require female , advice birth control provide 1 . Uncontrolled diabetes hypertension . 2 . Cardiac conduction abnormality uncontrolled arrhythmia . 3 . History blood dyscrasia , include leukemia . 4 . Significant active hepatic renal disease , include chronic hepatitis . 5 . Clinically significant neurological disorder , include ( limited ) Parkinson â€™ disease , multiple sclerosis , seizure disorder , intracranial mass lesion ( note presence tardive dyskinesia exclusion participant ) . 6 . Active cancer without chemotherapy within last five year ( include completely excise basal cell carcinoma ) . 7 . Active endocrinological disorder ( include adequately treated hypothyroidism ) . 8 . Pregnancy lactation . 9 . An active substance use disorder within last six month . 10 . History lack response adequate trial monotherapy either clozapine olanzapine dose clozapine must &gt; 600 mg/day dose olanzapine must &gt; 20 mg/day ; duration treatment either must &gt; 6 week . 11 . History intolerance clozapine olanzapine , include blood dyscrasia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2005</verification_date>
</DOC>